Detalles de la búsqueda
1.
A SARS-CoV-2 mini-genome assay based on negative-sense RNA to study replication inhibitors and emerging mutations
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-450211
2.
Shorter serial intervals in SARS-CoV-2 cases with Omicron variant compared to Delta variant in the Netherlands, 13 - 19 December 2021
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22269217
3.
Symptom presentation among SARS-CoV-2 positive cases and the impact of COVID-19 vaccination; three prospective household cohorts
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22278985
4.
Increased risk of infection with SARS-CoV-2 Omicron compared to Delta in vaccinated and previously infected individuals, the Netherlands, 22 November to 19 December 2021
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21268121
5.
Incidence rates and symptomatology of community infections with SARS-CoV-2 in children and parents: The CoKids longitudinal household study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267600
6.
Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22280189
7.
Regional importation and asymmetric within-country spread of SARS-CoV-2 variants of concern in the Netherlands
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22272611
8.
IgG1 responses following SARS-CoV-2 infection are polyclonal and highly personalized, whereby each donor and each clone displays a distinct pattern of cross-reactivity against SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-481778
9.
Protection of COVID-19 vaccination and previous infection against Omicron BA.1 and Delta SARS-CoV-2 infections, the Netherlands, 22 November 2021- 19 January 2022
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270457
10.
Increased risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variant compared to Alpha variant in vaccinated individuals
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21266735
11.
SARS-CoV-2 RNA and antibody dynamics in a Dutch household study with dense sampling frame
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21263384
12.
SARS-CoV-2 outbreaks in secondary school settings in the Netherlands during fall 2020; silent circulation
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22273861
13.
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-516125
14.
Impacts of the COVID-19 pandemic on future seasonal influenza epidemic
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270494
15.
Mapping the antigenic diversification of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21268582
16.
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256092
17.
Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected Individual
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-512216
18.
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21257441
Resultados
1 -
18
de 18
1
Próxima >
>>